Eupatilin attenuates TGF-β2-induced proliferation and epithelial-mesenchymal transition of retinal pigment epithelial cells

References

• Kim IK, Arroyo JG. Mechanisms in proliferative vitreoretinopathy. Ophthalmol Clin North Am 2002;15:81–86.
   PubMedGoogle Scholar
• Charteris DG. Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment. Br J Ophthalmol 1995;79:953–960.
   PubMed Web of Science ®Google Scholar
• Baudouin C, Hofman P, Brignole F, et al. Immunocytology of cellular components in vitreous and subretinal fluid from patients with proliferative vitreoretinopathy. Ophthalmologica 1991;203:38–46.
   PubMed Web of Science ®Google Scholar
• Feng XH, Derynck R. Specificity and versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev Biol 2005;21:659–693.
   PubMed Web of Science ®Google Scholar
• Connor TB, Jr., Roberts AB, Sporn MB, et al. Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. J Clin Invest 1989;83:1661–1666.
   PubMed Web of Science ®Google Scholar
• Ricker LJ, Kijlstra A, Kessels AG, et al. Interleukin and growth factor levels in subretinal fluid in rhegmatogenous retinal detachment: a case-control study. PLoS One 2011;6:e19141.
   PubMed Web of Science ®Google Scholar
• Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 2014;15:178–196.
   PubMed Web of Science ®Google Scholar
• Skovierova H, Okajcekova T, Strnadel J, et al. Molecular regulation of epithelial-to-mesenchymal transition in tumorigenesis (Review). Int J Mol Med 2018;41:1187–1200.
   PubMed Web of Science ®Google Scholar
• Tamiya S, Liu L, Kaplan HJ. Epithelial-mesenchymal transition and proliferation of retinal pigment epithelial cells initiated upon loss of cell-cell contact. Invest Ophthalmol Vis Sci 2010;51:2755–2763.
   PubMed Web of Science ®Google Scholar
• Ahmadieh H, Feghhi M, Tabatabaei H, et al. Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trial. Ophthalmology 2008;115:1938–1943.
   PubMed Web of Science ®Google Scholar
• Wickham L, Bunce C, Wong D, et al. Randomized controlled trial of combined 5-fluorouracil and low-molecular-weight heparin in the management of unselected rhegmatogenous retinal detachments undergoing primary vitrectomy. Ophthalmology 2007;114:698–704.
   PubMed Web of Science ®Google Scholar
• Assi A, Khoueir Z, Helou C, et al. Intraocular application of Mitomycin C to prevent proliferative vitreoretinopathy in perforating and severe intraocular foreign body injuries. Eye 2019;33:1261–1270.
   PubMed Web of Science ®Google Scholar
• Erdogan S, Turkekul K, Dibirdik I, et al. Midkine silencing enhances the anti-prostate cancer stem cell activity of the flavone apigenin: cooperation on signaling pathways regulated by ERK, p38, PTEN, PARP, and NF-κB. Invest New Drugs 2020;38:246–263.
   PubMed Web of Science ®Google Scholar
• Erdogan S, Doganlar O, Doganlar ZB, et al. The flavonoid apigenin reduces prostate cancer CD44(+) stem cell survival and migration through PI3K/Akt/NF-κB signaling. Life Sci 2016;162:77–86.
   PubMed Web of Science ®Google Scholar
• Ozal SA, Gurlu V, Turkekul K, et al. Neferine inhibits epidermal growth factor-induced proliferation and migration of retinal pigment epithelial cells through downregulating p38 MAPK and PI3K/AKT signalling. Cutan Ocul Toxicol 2020;39:97–105.
   PubMed Web of Science ®Google Scholar
• Cui HS, Li YM, Fang W, et al. Effect of berberine on lipopolysaccharide-induced monocyte chemotactic protein-1 and interleukin-8 expression in a human retinal pigment epithelial cell line. Int Ophthalmol 2018;38:2053–2060.
   PubMed Web of Science ®Google Scholar
• Park BB, Yoon J, Kim E, et al. Inhibitory effects of eupatilin on tumor invasion of human gastric cancer MKN-1 cells. Tumour Biol 2013;34:875–885.
   PubMedGoogle Scholar
• Jeong EK, Jang HJ, Kim SS, et al. Protective effect of eupatilin against renal ischemia-reperfusion injury in mice. Transplant Proc 2015;47:757–762.
   PubMed Web of Science ®Google Scholar
• Choi EJ, Lee S, Chae JR, et al. Eupatilin inhibits lipopolysaccharide-induced expression of inflammatory mediators in macrophages. Life Sci 2011;88:1121–1126.
   PubMed Web of Science ®Google Scholar
• Serttas R, Koroglu C, Erdogan S. Eupatilin inhibits the proliferation and migration of prostate cancer cells through modulation of PTEN and NF-kappaB signaling. Anticancer Agents Med Chem  2021;21:372–382.
   PubMed Web of Science ®Google Scholar
• Cho JH, Lee JG, Yang YI, et al. Eupatilin, a dietary flavonoid, induces G2/M cell cycle arrest in human endometrial cancer cells. Food Chem Toxicol 2011;49:1737–1744.
   PubMed Web of Science ®Google Scholar
• Lee CJ, Hong SH, Yoon MJ, et al. Eupatilin treatment inhibits transforming growth factor beta-induced endometrial fibrosis in vitro. Clin Exp Reprod Med 2020;47:108–113.
   PubMedGoogle Scholar
• Zhong WF, Wang XH, Pan B, et al. Eupatilin induces human renal cancer cell apoptosis via ROS-mediated MAPK and PI3K/AKT signaling pathways. Oncol Lett 2016;12:2894–2899.
   PubMed Web of Science ®Google Scholar
• Du L, Chen J, Xing YQ. Eupatilin prevents H2O2-induced oxidative stress and apoptosis in human retinal pigment epithelial cells. Biomed Pharmacother 2017;85:136–140.
   PubMed Web of Science ®Google Scholar
• Fei X, Wang J, Chen C, et al. Eupatilin inhibits glioma proliferation, migration, and invasion by arresting cell cycle at G1/S phase and disrupting the cytoskeletal structure. Cancer Manag Res 2019;11:4781–4796.
   PubMed Web of Science ®Google Scholar
• Kimoto K, Nakatsuka K, Matsuo N, et al. p38 MAPK mediates the expression of type I collagen induced by TGF-beta 2 in human retinal pigment epithelial cells ARPE-19. Invest Ophthalmol Vis Sci 2004;45:2431–2437.
   PubMed Web of Science ®Google Scholar
• Erdogan S, Turkekul K, Dibirdik I, et al. Midkine downregulation increases the efficacy of quercetin on prostate cancer stem cell survival and migration through PI3K/AKT and MAPK/ERK pathway. Biomed Pharmacother 2018;107:793–805.
   PubMed Web of Science ®Google Scholar
• Gonzalez DM, Medici D. Signaling mechanisms of the epithelial-mesenchymal transition. Sci Signal 2014;7:re8.
   PubMed Web of Science ®Google Scholar
• Bertoli C, Skotheim JM, de Bruin RA. Control of cell cycle transcription during G1 and S phases. Nat Rev Mol Cell Biol 2013;14:518–528.
   PubMed Web of Science ®Google Scholar
• Cargnello M, Roux PP. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev 2011;75:50–83.
   PubMed Web of Science ®Google Scholar
• Chen H, Wang H, An J, et al. Plumbagin induces RPE cell cycle arrest and apoptosis via p38 MARK and PI3K/AKT/mTOR signaling pathways in PVR. BMC Complement Altern Med 2018;18:89.
   PubMed Web of Science ®Google Scholar
• Zhou X, Kuang X, Long C, et al. Curcumin inhibits proliferation and epithelial-mesenchymal transition of retinal pigment epithelial cells via multiple pathways. Curr Mol Med 2017;17:312–319.
   PubMed Web of Science ®Google Scholar
• Wu Z, Zou B, Zhang X, et al. Eupatilin regulates proliferation and cell cycle of cervical cancer by regulating hedgehog signalling pathway. Cell Biochem Funct 2020;38:428–435.
   PubMed Web of Science ®Google Scholar
• Hazan RB, Qiao R, Keren R, et al. Cadherin switch in tumor progression. Ann NY Acad Sci 2004;1014:155–163.
   PubMed Web of Science ®Google Scholar
• Li Y, Ren R, Wang L, et al. Eupatilin alleviates airway remodeling via regulating phenotype plasticity of airway smooth muscle cells. Biosci Rep 2020;40:BSR20191445.
   PubMed Web of Science ®Google Scholar
• Markopoulos GS, Roupakia E, Marcu KB, et al. Epigenetic regulation of inflammatory cytokine-induced epithelial-to-mesenchymal cell transition and cancer stem cell generation. Cells 2019;8:1143.
   Web of Science ®Google Scholar
• Huang X, Dai S, Dai J, et al. Luteolin decreases invasiveness, deactivates STAT3 signaling, and reverses interleukin-6 induced epithelial-mesenchymal transition and matrix metalloproteinase secretion of pancreatic cancer cells. Onco Targets Ther 2015;8:2989–3001.
   PubMed Web of Science ®Google Scholar
• Park JY, Park DH, Jeon Y, et al. Eupatilin inhibits angiogenesis-mediated human hepatocellular metastasis by reducing MMP-2 and VEGF signaling. Bioorg Med Chem Lett 2018;28:3150–3154.
   PubMed Web of Science ®Google Scholar
• Jung Y, Kim JC, Choi Y, et al. Eupatilin with PPARα agonistic effects inhibits TNFα-induced MMP signaling in HaCaT cells. Biochem Biophys Res Commun 2017;493:220–226.
   PubMed Web of Science ®Google Scholar
• Sapkota A, Gaire BP, Cho KS, et al. Eupatilin exerts neuroprotective effects in mice with transient focal cerebral ischemia by reducing microglial activation. Plos One 2017;12:e0171479.
   PubMed Web of Science ®Google Scholar
• Kwon OW, Song JH, Roh MI. Retinal detachment and proliferative vitreoretinopathy. Retinal Pharmacotherapeutics. Basel, Switzerland: Karger Publishers; 2016:154–162.
   Google Scholar
• Lin H-Y, Chen Y-S, Wang K, et al. Fisetin inhibits epidermal growth factor–induced migration of ARPE-19 cells by suppression of AKT activation and Sp1-dependent MMP-9 expression. Mol Vision 2017;23:900–910.
   PubMed Web of Science ®Google Scholar
• Wang H-F, Ma J-X, Shang Q-L, et al. Crocetin inhibits the proliferation, migration and TGF-β2-induced epithelial-mesenchymal transition of retinal pigment epithelial cells. Eur J Pharmacol 2017;815:391–398.
   PubMed Web of Science ®Google Scholar